Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Enhanced insulin sensitivity obtained in insulin-resistant obese rats treated with BIM-23268

July 9, 2001

Alkoxyiminoalkanoic acid derivatives for the prevention, treatment of diabetes

July 6, 2001

Phytopharm's P-57 successfully completes second stage of obesity study

July 6, 2001

Additional beneficial effects reported for ezetimibe in a hamster model of combined dyslipidemia

July 6, 2001

CLX-090700: a synthetic analogue of a natural product with oral antidiabetic properties

July 6, 2001

Amgen awaits FDA decision on ARANESP

July 6, 2001

Improved stability and in vivo activity achieved in novel human GLP-1 analogues

July 6, 2001

Novel compounds synthesized at Fujimoto useful for hyperlipidemia

July 5, 2001

Merck KGaA presents new modified EPO forms

July 5, 2001

U.S. university researchers design potent and selective human MC4 receptor agonist

July 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...